The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
AusPAR: Mogamulizumab
Australian Public Assessment Report
Device/Product Name
Poteligeo
Active ingredients
Mogamulizumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-00700-1-6
Submission Type
New biological entity
Decision
Approved